November 21, 2016
November 21, 2016 —
The next presentation in UC San Diego’s “Inside Innovation” series features professors Andrew Kahn and Juan C. del Alamo discussing their latest research into quantifying a person’s risk for stroke through analyzing blood flow through the heart.
September 9, 2014
September 9, 2014 —
Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.
August 28, 2013
August 28, 2013 —
A researcher at the University of California, San Diego School of Medicine is among principal investigators at 10 California institutions receiving Early Translational IV Research grants, totaling $40 million, approved today by the governing board of the California Institute for Regenerative Medicine (CIRM) at its meeting in San Diego.
March 3, 2017
March 3, 2017 —
UC San Diego Research Affairs –The Office of Innovation and Commercialization launches the first of an eighteen-month entrepreneurial seminar series, free and open to anyone at UC San Diego and the general public, including members of any other research institutions, Mar. 9.
June 8, 2015
June 8, 2015 —
The Sanford Consortium for Regenerative Medicine in La Jolla, California, and the Takeda Pharmaceutical Company Limited (Takeda) have agreed to establish a $10-million, five-year Innovation Alliance that would advance each organization’s research missions.
January 20, 2017
January 20, 2017 —
…the California Institute for Regenerative Medicine (CIRM) has approved a pair of $2 million awards to University of California San Diego School of Medicine researchers to advance studies of new treatments for Zika virus infections and the use of stem cell-derived natural killer (NK) cells to target ovarian cancer and…
October 23, 2014
October 23, 2014 —
In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new “alpha clinics” by the California Institute for Regenerative Medicine, the state’s stem cell agency.
October 10, 2024
October 10, 2024 —
Funded by a California Institute for Regenerative Medicine grant, researchers in the UC San Diego Verge Center aim to uncover the genetic mechanisms behind neuropsychiatric disorders.
May 5, 2015
May 5, 2015 —
…researchers at University of California, San Diego School of Medicine used a powerful statistical tool called “design of experiments” to determine the optimal cell culture formula to grow and produce hPSCs.
February 2, 2015
February 2, 2015 —
The governing board of the California Institute for Regenerative Medicine (CIRM) has awarded two University of California, San Diego researchers almost $3 million in combined funding to pursue new technologies intended to accelerate advances moving stem cell therapies out of the lab and into the clinic.